Ema: "Possible links between J&J vaccine and rare thrombosis events"
The clarification: "The benefits outweigh the risks"
The European Medicines Agency (EMA) recognizes "possible" cause-and-effect links between the Johnson & Johnson vaccine and the "very rare" events of cerebral thrombosis that have occurred in the US.
This is what we read in a note from the EU agency which states that the benefits outweigh the risks.
The EMA then specifies how in the administration of Janssen, the Johnson & Johnson vaccine, "the benefits outweigh the risks".
The clarification came at the end of the serum review, after very rare cases of cerebral thrombosis in the United States.
(Unioneonline / vl)